Kyle Rafferty Biomedical Engineering. Overview  What are CTC’s?  Why is detection important?  Older methods of detection Immunomagnetic beads Flat.

Slides:



Advertisements
Similar presentations
Molecular tests for the detection of prostate tumor derived nucleic acids in peripheral blood Matthias Jost, PhD 1, John Day, PhD 1, Ryan Slaughter 1,
Advertisements

Solar Cells and Integration of Nanotechnology Organic/Inorganic solar cells Silicon solar cells are most common and efficient right now. Reflection of.
Understanding Cancer and Related Topics Understanding Nanodevices
Circulating Tumor Cells and Their Prognostic and Predictive Value in Breast Cancer Massimo Cristofanilli, M.D., F.A.C.P. Professor and Chairman Medical.
Shyamala Maherswaran, Ph.D. et al. Sarah Gomez and Rachael Holmes Detection of Mutations in EGFR in Circulating Lung-Cancer Cells.
Circulating Tumor Cells (CTCs) - Detection and isolation technologies.
Presented by: Robert O'Brien Training Specialist – Forensic Biology
The War on Cancer: 41 years after Nixon’s Declaration Mark Clanton, MD, MPH, Chief Medical Officer, American Cancer Society, High Plains Division.
Circulating Tumor Cells
Advances in Early Diagnosis and Treatment of Cancer July 17, 2007.
Cell Separation Using Magnetic Beads
Introduction to Immunoassays
Nanotechnology Introduction ENGR Pre Reading Slides.
Detection of Mutations in EGFR in Circulating Lung-Cancer Cells Colin Reisterer and Nick Swenson S. Maheswaran et al. The New England Journal of Medicine.
Circulating Tumor Cells Minetta C. Liu, MD Associate Professor of Medicine and Oncology Director, Translational Breast Cancer Research Lombardi Comprehensive.
Isolation of Rare Circulating Tumor Cells in Cancer Patients by Microchip Technology Toner, et al Stephanie Bachar Matt Luchette.
CT Scans Advances in Technology help cure cancer. By: Kristin Day.
Isolation of Rare Circulating Tumor Cells Sunitha Nagrath et al. Presentation.
Objective DNA amplification (eg. PCR)    advances in forensic, clinical applications Comparable protein amplification tools (?)  aid medical diagnostics,
Isolation of rare circulating tumor cells in cancer patients by microchip technology Nagrath & Sequist et al. (2007) Journal Presentation Brigitte Morales.
Circulating tumor cells (CTCs) in blood of breast cancer patients: Cytological detection and technical characterization Enrica Bresaola, Mara Jo Miller,
Female Cancer Fatima Reyadh Mrs. Timm 12A March 10, 2013.
Britney Porter, Sandra Nguyen, Eduardo Vargas and Samender Singh Randhawa What techniques are utilized to develop a personalized diagnosis for cancer patients?
Tiffany M. Marshall Saint Mary-of-the-Woods College Mentors : Tim McKnight Measurement Science and Systems.
Towards a fast, efficient assay for isolating circulating tumor cells
Multiple Myeloma Presented by: Mike Lynch Mike Lynch.
Breast and Thyroid Cancer Detection Using Immunomagnetic Beads By: Rami Abdelghafar & Pankaj K. Saha Memorial Sloan-Kettering Cancer Center Dr. Sat Bhattacharya.
When will the diagnosis of Circulating tumor cells (CTC) help to patients? Martin Pešta, Ondřej Topolčan Department of Internal Medicine II, Faculty of.
ELISA Assay. What Is It? Enzyme immunoassay (EIA) is a test used to detect and quantify specific antigen-eliciting molecules involved in biological processes,
SAP Innovation Center Potsdam Dominik Bertram 28. November 2013.
By: John Rawls.  There are over 100 types of Cancer  Over 7 million deaths a year (2004)  Makes up over 13% of the world’s deaths each year  The disease.
Field-Induced Magnetic Nanoparticle Drug Delivery BME 273 Group 15 Team Leader : Ashwath Jayagopal (BME, EE, MATH) Members : Sanjay Athavale (BME) and.
APPLICATIONS OF MONOCLONAL ANTIBODIES
Antibody Detection. Part II Detection of Antigens Western Blotting “Dot-Blot Assay” Positive Control Primary antibody (IgY) Lysed E. Coli Cells Lysed.
吳 華 席 Hua-Hsi Wu, MD OB/GYN, VGH-TPE Aug 12, 2008
Microtube Device for Selectin- Mediated Capture of Viable Circulating Tumor Cells from Blood A.D. Hughes, J. Mattison, L.T. Western, J.D. Powderly, B.T.
Sunitha Nagrath, Lecia V. Sequist, Shyamala Maheswaran, Daphne W. Bell, Daniel Irimia, Lindsey Ulkus, Matthew R. Smith, Eunice L. Kwak, Subba Digumarthy,
POSTER TEMPLATE BY: Fabrication of Nanobiosensors Tom Fitzgerald, Nathan Howell, Brian Maloney Oregon State University, Department.
Nanotechnology The concept of nanotechnology is defined as an art handling of tiny particles (1nm= m). The structures have different properties.
AGA/ASCO/ASTRO/SSO Gastrointestinal Cancers Symposium Orlando, FL January 26, 2008 Circulating tumor cells: are they predictive markers? Neal J. Meropol,
Pulmonary Venous Blood Sampling Significantly Increases the Yield of Circulating Tumor Cells in Early Stage Lung Cancer Reddy RM, Murlidhar V 2, Zhao L.
AppliChem © There is another top address in Darmstadt! very common applications: (a) biochemistry (wash or blocking buffer) (b) cell biology (suspend.
Nanotechnology Introduction
Biomedical Science Activity ELISA
“Isolation of rare circulating tumour cells in cancer patients by microchip technology” Nagrath et al. Nature 2007 Peter Bojo.
NANOTECHNOLOGY IN CANCER TREATMENT
AmirAli H. Talasaz, Ashley A. Powell, David E. Huber, James G. Berbee, Kyung-Ho Roh, Wong Yu, Wenzhong Xiao, Mark M. Davis, R. Fabian Pease, Michael N.
KYLE RETZER COSC 380 Nanotechnology. Roadmap The Nanoscale. What is it? Starting point. Nanotechnology today. How is it useful?
CT Scan vs MRI.
Fluorescence intensity
Absorbance: Enzyme Linked Immunosorbent Assays (ELISA)
Epithelial-to-Mesenchymal Transitions Circulating Tumor Cells
Chemiluminecent microparticle)) immunoassay
Chemiluminecent microparticle MEIA)) immunoassay
Sencet BioFIT 2016 Start-up Slams.
Techniques for measuring minimal residual disease in leukemia
Building better therapy for children with acute lymphoblastic leukemia
DNA Technology.
بهداشت فردي.
ELISA Immuno ExlorerTM HIV/AIDS Diagnostic Tool
Impact of efficient and inefficient therapies on CTCs and ctDNA.
ELISA Immuno ExlorerTM HIV/AIDS Diagnostic Tool
The CTC-Chip: An Exciting New Tool to Detect Circulating Tumor Cells in Lung Cancer Patients  Lecia V. Sequist, MD, MPH, Sunitha Nagrath, PhD, Mehmet.
Adaptamers Thrombin-binding domain Streptavidin-binding domain
Circulating Tumor Cells in Pulmonary Venous Blood of Primary Lung Cancer Patients  Yoshitomo Okumura, MD, Fumihiro Tanaka, MD, PhD, Kazue Yoneda, Masaki.
What Can Immunology Tells Us About Breast Cancer?
Treatment of human MCC tumors with intralesional IFNβ is associated with MHC-I upregulation. Treatment of human MCC tumors with intralesional IFNβ is associated.
Christian Möbs, Thomas Schmidt  Journal of Investigative Dermatology 
Adaptamers Target A Target B Adaptamer.
Presentation transcript:

Kyle Rafferty Biomedical Engineering

Overview  What are CTC’s?  Why is detection important?  Older methods of detection Immunomagnetic beads Flat silicon substrates  New Advancement Silicon nanopillar substrate  Sources

CTC’s  Circulating Tumor Cells  Metastasis  Deadly Cancer becoming biggest killer in world (WHO) Most common death from metastasis  Helpful to know amount in bloodstream Examining cancer metastasis Predicting patient prognosis Monitoring cancer

Previous Methods  Immunomagnetic Beads “Utilizes capture-agent-coated magnetic beads to immunologically recognize CTCs in the blood, followed by magnetic isolation. However, these bead-based approaches are limited by their low CTC-capture yield and purity.” Use ferrofluids(microscopic iron particles)/antibodies and magnets to extract CellSearch  Flat Silicon Substrate 1x2 cm silicon chip Coated with streptavidin and anti-EpCAM (epithelial cell adhesion molecule antibody)

Silicon Nanopillar Substrate  Build much like flat silicon 1x2 cm silicon ship Built by lithographic tools used for computer chips  Difference: Nanopillars Diameter~ nm; Length~20um  Also coated with streptavidin and anti- EpCAM (epithelial cell adhesion molecule antibody)

SiNP Substrate cont.  Researchers found maximum cell- capture numbers were at 45 min. incubation time As compared to 3-4 hrs for previous method  This is more efficient and therefore would probably cut costs PBS: Phosphate buffered Saline. Very common biological solution.

Diagram: how SiNP works

Diagram: Si vs. SiNP

Future Use  Researchers hope to achieve 84-91% detection  Will allow faster detection of cancer’s  Allow Doctor’s to customize treatment plan  Increase early detection and survival rates

Sources  Wang, Shutao. “Three-Dimensional Nanostructured Substrates toward Efficient Capture of Circulating Tumor Cells.” Angewandte Chemie International Edition 48 (2009): Jan bin/fulltext/ /PDFSTART (impact factor: )  (2) Berger, Michael. “Nanotechnology trap captures cancer cells in blood.” Nanowerk, Nov Jan  Wikipedia contributors. "Metastasis." Wikipedia, The Free Encyclopedia. Wikipedia, The Free Encyclopedia, 23 Jan Web. 26 Jan  Stobbe, Mike. “Cancer top killer in world by 2010.” The Seattle Times, 10 Dec Jan html